| Product Name | Model Number | Dimensions |
|---|---|---|
| Research Peptide | 5mg 10mg 20mg Vials | 10 vials/kit |
| Peptide | 5mg 10mg 20mg Vials | 10 vials/kit |
Advantages
1)All purity>99%.
2)High quality with competitive price.
3)We are manufacturer and can provide high quality products with factory price.
Telpotide is a new type of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist that can bind to albumin and prolong its half-life. Telpotide can enhance phase I and II insulin secretion and reduce glucagon levels, both of which are glucose-dependent. It can reduce fasting and postprandial glucose concentrations in patients with type 2 diabetes, reduce food intake, and lose weight .
Tipol is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
In a 40-week phase 3 open-label trial, 1879 patients were randomly assigned in a 1:1:1:1 ratio to receive 5 mg, 10 mg, or 15 mg of tepoxetine or 1 mg of semaglutide. At baseline, the mean glycated hemoglobin level was 8.28%, the mean age was 56.6 years, and the mean weight was 93.7 kg.
The estimated mean changes from baseline in glycated hemoglobin levels were -2.01%, -2.24%, and -2.30% for patients taking 5 mg, 10 mg, and 15 mg of tirpotide, respectively, and -1.86% for patients taking semaglutide.
